表紙
市場調査レポート

動脈血栓症:世界の治験レビュー

Arterial Thrombosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 311437
出版日 ページ情報 英文 65 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
動脈血栓症:世界の治験レビュー Arterial Thrombosis Global Clinical Trials Review, H2, 2014
出版日: 2014年08月25日 ページ情報: 英文 65 Pages
概要

当レポートでは、動脈血栓症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、主な先進国・新興国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

  • 動脈血栓症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:心血管関連の治験における動脈血栓症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管関連の治験における動脈血栓症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

動脈血栓症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • AstraZeneca PLC
    • Arena Pharmaceuticals, Inc.
    • 武田薬品工業
    • Hanwha Chemical Co., Ltd.
    • Ildong Pharmaceutical Co., Ltd.
    • Bristol-Myers Squibb Company
  • 代表的な研究機関・病院の治験の概要
    • Tufts Medical Center
    • The Newcastle upon Tyne Hospitals NHS Foundation Trust
    • Sheffield Teaching Hospitals NHS Foundation Trust
    • Meir Medical Center
    • St. Antonius Hospital
    • British Heart Foundation
    • All India Institute of Medical Sciences
    • University of Oxford
    • Hopitaux Universitaires de Geneve

5つの代表的な治験のプロファイル

付録

目次

GlobalData's clinical trial report, "Arterial Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Arterial Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Arterial Thrombosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Arterial Thrombosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Arena Pharmaceuticals, Inc.
      • Clinical Trial Overview of Arena Pharmaceuticals, Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Hanwha Chemical Co., Ltd.
      • Clinical Trial Overview of Hanwha Chemical Co., Ltd.
      • Ildong Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Ildong Pharmaceutical Co., Ltd.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
    • Clinical Trial Overview of Top Institutes / Government
      • Tufts Medical Center
      • Clinical Trial Overview of Tufts Medical Center
      • The Newcastle upon Tyne Hospitals NHS Foundation Trust
      • Clinical Trial Overview of The Newcastle upon Tyne Hospitals NHS Foundation Trust
      • Sheffield Teaching Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust
      • Meir Medical Center
      • Clinical Trial Overview of Meir Medical Center
      • St. Antonius Hospital
      • Clinical Trial Overview of St. Antonius Hospital
      • British Heart Foundation
      • Clinical Trial Overview of British Heart Foundation
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Hopitaux Universitaires de Geneve
      • Clinical Trial Overview of Hopitaux Universitaires de Geneve
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Arterial Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Arterial Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arena Pharmaceuticals, Inc., 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanwha Chemical Co., Ltd., 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ildong Pharmaceutical Co., Ltd., 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts Medical Center, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Newcastle upon Tyne Hospitals NHS Foundation Trust, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Meir Medical Center, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by British Heart Foundation, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2014*

List of Figures

  • Arterial Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Arterial Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Arterial Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Arterial Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top